Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs for ...

Ventus Therapeutics enters agreement with Genentech to discover and develop small-molecule medicines using Ventus’ ReSOLVE platform: Waltham, Massachusetts Thursday, October 23, ...

Lake Technical College is presenting its annual Career TechXpo soon highlighting programs in healthcare, manufacturing, ...

XGD:CA offers diversified exposure to leading global gold producers, outperforming bullion ETFs during recent gold rallies.

Detailed price information for Corcept Therapeutics (CORT-Q) from The Globe and Mail including charting and trades.

Major stock indexes finished mixed on a busy day of corporate news Tuesday, with the Dow Jones Industrial Average setting ...

The Q3 of Insilico Medicine's Pharma.AI Quarterly Launch webinar—titled “Towards Pharmaceutical Superintelligence” —was ...

An index tracking companies that enable gambling, day trading, and crypto speculation has returned 130% since May 2023.

A Detroit News-WDIV-TV poll of 500 likely Detroit voters shows how they feel about crime, the mayor, the council and leaving ...

Updated Phase 1 givastomig monotherapy data show an impressive 18% ORR in metastatic gastric cancer patients who had received at least two prior ...

Netflix NFLX reported third-quarter 2025 earnings of $5.87 per share, which missed the Zacks Consensus Estimate by 14.8%. The ...